CCL2 and neoplasm: Meanwhile, the blockade of the CCL2 signaling pathway resulted in decreased recruitment of inflammatory monocytes and macrophages in the tumor microenvironment, forming an immunosuppressive phenotype and conferred cancer cells proliferation [53].